We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Overview of the UK's cardiovascular disease research infrastructure and advantage of investment in the UK's life science sector to support new treatments.
Projects granted during 2015 that have a primary purpose of translational and applied research: cardiovascular disorders.
Update of cardiovascular disease (CVD) profile indicators for stroke data for clinical commissioning groups.
The Charity Commission has opened a statutory inquiry into the Have A Heart Foundation.
Projects granted during 2014 that have a primary purpose of basic research into the cardiovascular, blood and lymphatic system.
Deaths registered in 2019 in England and Wales due to ischaemic heart diseases, by sex, age group, ethnicity, region and place of occurrence. Includes analysis of comorbidities.
Health and Social Care Secretary Steve Barclay has announced measures to tackle aortic dissection, a heart condition that kills 2,000 people every year.
You may need to tell DVLA if you have cardiac problems - download the correct form if you need to let them know
These reports assess cardiovascular disease in the south-west, focusing on risk factors, heart disease, stroke, kidney disease and diabetes.
Report by the Committee on the Medical Effects of Air Pollutants describing how long-term exposure to ambient air pollution can lead to cardiovascular disease.
Caution is required if prescribing febuxostat in patients with pre-existing major cardiovascular disease, particularly, in those with evidence of high urate crystal and tophi burden or those initiating urate-lowering therapy.
This report examines the current evidence about cardiovascular disease in the North East of England.
This document contains a synopsis of causation occurring in coronary heart disease.
This study aims to estimate the costs of Cardiovascular Disease and the costs of Diabetes Mellitus to individuals and society
Check if you need to tell DVLA about a health or medical condition, how to report medical conditions to DVLA
This document explains the NHS view on private screening for different conditions and diseases.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).